Discover, Develop and Selectively Deliver Highly Stable and Potent RNAi Therapeutics for Targeted and Effective Gene Silencing in Oncology, Rare, Cardiovascular Disorders and Beyond

The 7th RNAi-Based Therapeutics Summit is the industry’s premier dedicated forum for translating the next wave of siRNA and microRNA drugs from bench to bedside.

Time: 8:00 am to 4:30 pm

Speakers: Andrew Coles, Senior Scientist, Abbvie, Muthiah Manoharan, Senior Vice President, Innovation Chemistry, Alnylam Pharmaceuticals and More

Venue details: Wyndham Boston Beacon Hill, 5 Blossom Street, Boston, Massachusetts, 02114, United States